Contact us

Plant

  • SCROLL

Lighting the way to your finished ATMP

Top-tier manufacturing & Europe-wide distribution
Along with our expertise in the design and development of advanced therapies, we also support you with top-tier infrastructure and capabilities for producing ATMPs under the highest standards of quality and regulatory compliance. At Idea Therapeutics we have established a strategic alliance with Cellab CDMO for the manufacturing of ATMPs.

Choose Idea Therapeutics as your trusted partner for your cell and gene therapy development and manufacturing. Contact us today to learn more about our services and how we can help bring your therapy to market faster.

  • Collection of ASC (Adipose stem cells)
  • Enrichment and depletion: equipped with a CliniMACS system
  • Activation, gene delivery and expansion: 700+ billion cells maximum throughput
  • Cryopreservation: 40.000+ units

Strategic location in Andorra

EU batch release, delivering across Europe

Lighting the way from your IND to the market

Streamline your journey from your IND (Investigational New Drug) to the market with a seamless CMC (Chemistry, Manufacturing and Controls) strategy, guided by a team with extensive expertise in advancing cell and gene therapies from early-stage discovery to successful commercialization. Our cell and gene therapy expertise covers a wide range of modalities, including autologous and allogeneic T-cell therapies (CAR-T, TCR, Treg), NK cells, iPSCs, MSCs, Extracellular Vesicles & Non-Cellular based therapies, and more.

With expertise in cell culture and both viral and non-viral genetic modification, we support a wide range of cell types, ensuring high-quality production for cell and gene therapy applications.

Our most relevant expertise includes:

  • Mesenchymal Stem Cells (MSC): From different sources: Umbilical cord tissue, Adipose tissue and Bone Marrow with a highly scalable process that preserves the therapeutic qualities of the cells.
  • Induced Pluripotent Stem Cells (iPSC): Reprogramming, expansion, and differentiation.
  • Hematopoietic Stem Cells (HSC): Isolation, selection, expansion, and genetic modification. Extensive expertise in different expansion platforms and bioreactors for CD34+ stem cells.
  • Stromal Vascular Fraction (SVF): Cell-rich fraction from adipose tissue for regenerative medicine applications.
  • T-Cells (including CAR-T and TCR-T): Engineered using viral and non-viral gene modification methods and expanded in different bioreactors.
  • Regulatory T Cells (Tregs): Isolated from leukapheresis, umbilical cord blood, bone marrow, or thymus.
  • Natural Killer (NK) Cells: Expansion and activation strategies for immunotherapy. Engineered using viral and non-viral gene modification methods.
  • Leukocytes & Monocytes: Isolation and processing for personalized medicine.
  • Extracellular Vesicles (EVs) and Secretome: Scalable production using bioreactors.
  • Platelet-Rich Plasma (PRP): Processing and quality-controlled manufacturing for therapeutic applications

Discover our scope of services at Cellab CDMO

Process Development

• GMP Bioprocess Design
• Scale-up
• Cryopreservation strategy
• Potency assays
• Donor or tissue selection
• Stability testing

GMP & GMP Like Manufacturing

• Cell separation
• Gene editing
• Cell expansion and conditioning
• Fill and Finish
• Cryopreservation and cell banking

Quality Control

• Mycoplasma
• Morphology
• Cell count
• Viability
• Identity
• Purity
• Sterility

Logistics

• EU Batch Release
• GMP Bank
• Custom Clearance Service
• Transport Validation
• Shipping Worldwide